Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Granuloma, Plasma Cell × Crizotinib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4 Lymphoid 2 Thoracic 1 Sarcoma 1

Conditions

Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma, Alveolar 1 Lymphoma, Large-Cell, Anaplastic 1 Granuloma, Plasma Cell 1

Interventions

pazopanib 2 Ifosfamide 2 Doxorubicin 2 selinexor 1 repotrectinib 1 ceritinib 1 Suspensions 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Crizotinib 1 Capsules 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01524926 2023-12-11

CREATE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

LymphoidPlasma cellSarcoma

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic, Sarcoma, Clear Cell, Rhabdomyosarcoma, Alveolar, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡